跳至主要内容
临床试验/NCT06467903
NCT06467903招募中不适用

A Prospective, Comparative Multicenter Evaluation Conducted to Capture Patients With Diabetic Retinopathy in General Practitioners, Using the SW as Medical Device and the SW as MD Comparator, When Evaluating the Patient's Retinal Image

Bonmedix Holding a.s.1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2024年6月7日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,000
试验地点
1
主要终点
Sensitivity and specificity

研究概览

简要总结

A prospective, comparative multicenter evaluation conducted to capture patients with diabetic retinopathy in general practitioners, using AI medical device

详细描述

A prospective, comparative multicenter evaluation conducted to capture patients with diabetic retinopathy in general practitioners, using the SWaMD medical device and the SWaMD comparator, when evaluating the patients retinal image

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women aged ≥ 40 years
  • Signed informed consent
  • Confirmed type 1 or 2 diabetes mellitus

排除标准

  • Ocular findings that do not allow retinal photography (significant nystagmus, corneal leukoma, dense cataract, hemophthalmus, etc.)
  • Patient has a condition or is in a situation that, in the opinion of the investigator, may bias the results of the study, may significantly interfere with the patient's participation in the investigation, or may result in unproducible photographs of a dilated ocular fundus
  • Patients with restrictions on personal freedom by administrative or legal order

结局指标

主要结局

Sensitivity and specificity

时间窗: 3 months

The sensitivity and specificity will be calculated using the evaluation of independent masked expert (ophthalmologist) as gold standard.

次要结局

未报告次要终点

研究者

发起方
Bonmedix Holding a.s.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验